192 related articles for article (PubMed ID: 35384155)
21. Association of MAPT Subhaplotypes With Risk of Progressive Supranuclear Palsy and Severity of Tau Pathology.
Heckman MG; Brennan RR; Labbé C; Soto AI; Koga S; DeTure MA; Murray ME; Petersen RC; Boeve BF; van Gerpen JA; Uitti RJ; Wszolek ZK; Rademakers R; Dickson DW; Ross OA
JAMA Neurol; 2019 Jun; 76(6):710-717. PubMed ID: 30882841
[TBL] [Abstract][Full Text] [Related]
22. [Progressive supranuclear palsy; an unusual form of parkinsonism].
Donker Kaat L; Boon AJ; Heutink P; van Swieten JC
Ned Tijdschr Geneeskd; 2004 Mar; 148(11):519-23. PubMed ID: 15054950
[TBL] [Abstract][Full Text] [Related]
23. Clinical Phenotypes of Progressive Supranuclear Palsy-The Differences in Interleukin Patterns.
Madetko-Alster N; Otto-Ślusarczyk D; Wiercińska-Drapało A; Koziorowski D; Szlufik S; Samborska-Ćwik J; Struga M; Friedman A; Alster P
Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37894815
[TBL] [Abstract][Full Text] [Related]
24. Clinicopathological features of progressive supranuclear palsy with asymmetrical atrophy of the superior cerebellar peduncle.
Koizumi R; Akagi A; Riku Y; Sone J; Miyahara H; Tanaka F; Yoshida M; Iwasaki Y
Neuropathology; 2023 Jun; 43(3):233-243. PubMed ID: 36222051
[TBL] [Abstract][Full Text] [Related]
25. Case report of a patient with unclassified tauopathy with molecular and neuropathological features of both progressive supranuclear palsy and corticobasal degeneration.
Koga S; Metrick MA; Golbe LI; Santambrogio A; Kim M; Soto-Beasley AI; Walton RL; Baker MC; De Castro CF; DeTure M; Russell D; Navia BA; Sandiego C; Ross OA; Vendruscolo M; Caughey B; Dickson DW
Acta Neuropathol Commun; 2023 Jun; 11(1):88. PubMed ID: 37264457
[TBL] [Abstract][Full Text] [Related]
26. Characteristics of progressive supranuclear palsy presenting with corticobasal syndrome: a cortical variant.
Ling H; de Silva R; Massey LA; Courtney R; Hondhamuni G; Bajaj N; Lowe J; Holton JL; Lees A; Revesz T
Neuropathol Appl Neurobiol; 2014 Feb; 40(2):149-63. PubMed ID: 23432126
[TBL] [Abstract][Full Text] [Related]
27. Clinical outcomes of progressive supranuclear palsy and multiple system atrophy.
O'Sullivan SS; Massey LA; Williams DR; Silveira-Moriyama L; Kempster PA; Holton JL; Revesz T; Lees AJ
Brain; 2008 May; 131(Pt 5):1362-72. PubMed ID: 18385183
[TBL] [Abstract][Full Text] [Related]
28. The MAPT p.E342K and p.R406W mutations are associated with progressive supranuclear palsy with atypical features.
Badihian N; Ali F; Botha H; Savica R; Machulda MM; Clark HM; Stierwalt JAG; Pham NTT; Baker MC; Rademakers R; Lowe V; Whitwell JL; Josephs KA
Parkinsonism Relat Disord; 2024 Feb; 119():105962. PubMed ID: 38134678
[TBL] [Abstract][Full Text] [Related]
29. Shared genetic risk between corticobasal degeneration, progressive supranuclear palsy, and frontotemporal dementia.
Yokoyama JS; Karch CM; Fan CC; Bonham LW; Kouri N; Ross OA; Rademakers R; Kim J; Wang Y; Höglinger GU; Müller U; Ferrari R; Hardy J; ; Momeni P; Sugrue LP; Hess CP; James Barkovich A; Boxer AL; Seeley WW; Rabinovici GD; Rosen HJ; Miller BL; Schmansky NJ; Fischl B; Hyman BT; Dickson DW; Schellenberg GD; Andreassen OA; Dale AM; Desikan RS
Acta Neuropathol; 2017 May; 133(5):825-837. PubMed ID: 28271184
[TBL] [Abstract][Full Text] [Related]
30. Rainwater Charitable Foundation criteria for the neuropathologic diagnosis of progressive supranuclear palsy.
Roemer SF; Grinberg LT; Crary JF; Seeley WW; McKee AC; Kovacs GG; Beach TG; Duyckaerts C; Ferrer IA; Gelpi E; Lee EB; Revesz T; White CL; Yoshida M; Pereira FL; Whitney K; Ghayal NB; Dickson DW
Acta Neuropathol; 2022 Oct; 144(4):603-614. PubMed ID: 35947184
[TBL] [Abstract][Full Text] [Related]
31. Identification of common variants influencing risk of the tauopathy progressive supranuclear palsy.
Höglinger GU; Melhem NM; Dickson DW; Sleiman PM; Wang LS; Klei L; Rademakers R; de Silva R; Litvan I; Riley DE; van Swieten JC; Heutink P; Wszolek ZK; Uitti RJ; Vandrovcova J; Hurtig HI; Gross RG; Maetzler W; Goldwurm S; Tolosa E; Borroni B; Pastor P; ; Cantwell LB; Han MR; Dillman A; van der Brug MP; Gibbs JR; Cookson MR; Hernandez DG; Singleton AB; Farrer MJ; Yu CE; Golbe LI; Revesz T; Hardy J; Lees AJ; Devlin B; Hakonarson H; Müller U; Schellenberg GD
Nat Genet; 2011 Jun; 43(7):699-705. PubMed ID: 21685912
[TBL] [Abstract][Full Text] [Related]
32. Cathepsin S increases tau oligomer formation through limited cleavage, but only IL-6, not cathespin S serum levels correlate with disease severity in the neurodegenerative tauopathy progressive supranuclear palsy.
Nübling G; Schuberth M; Feldmer K; Giese A; Holdt LM; Teupser D; Lorenzl S
Exp Brain Res; 2017 Aug; 235(8):2407-2412. PubMed ID: 28493068
[TBL] [Abstract][Full Text] [Related]
33. Parkin polymorphisms in progressive supranuclear palsy.
Ros R; Ampuero I; García de Yébenes J
J Neurol Sci; 2008 May; 268(1-2):176-8. PubMed ID: 18022644
[TBL] [Abstract][Full Text] [Related]
34. The MAPT gene is differentially methylated in the progressive supranuclear palsy brain.
Huin V; Deramecourt V; Caparros-Lefebvre D; Maurage CA; Duyckaerts C; Kovari E; Pasquier F; Buée-Scherrer V; Labreuche J; Behal H; Buée L; Dhaenens CM; Sablonnière B
Mov Disord; 2016 Dec; 31(12):1883-1890. PubMed ID: 27709663
[TBL] [Abstract][Full Text] [Related]
35. Genetics of Progressive Supranuclear Palsy.
Im SY; Kim YE; Kim YJ
J Mov Disord; 2015 Sep; 8(3):122-9. PubMed ID: 26413239
[TBL] [Abstract][Full Text] [Related]
36. The PSP-associated MAPT H1 subhaplotype in Guadeloupean atypical parkinsonism.
Camuzat A; Romana M; Dürr A; Feingold J; Brice A; Ruberg M; Lannuzel A
Mov Disord; 2008 Dec; 23(16):2384-91. PubMed ID: 18785640
[TBL] [Abstract][Full Text] [Related]
37. Progressive supranuclear palsy and corticobasal degeneration: lumping versus splitting.
Scaravilli T; Tolosa E; Ferrer I
Mov Disord; 2005 Aug; 20 Suppl 12():S21-8. PubMed ID: 16092076
[TBL] [Abstract][Full Text] [Related]
38. Contribution of the astrocytic tau pathology to synapse loss in progressive supranuclear palsy and corticobasal degeneration.
Briel N; Pratsch K; Roeber S; Arzberger T; Herms J
Brain Pathol; 2021 Jul; 31(4):e12914. PubMed ID: 33089580
[TBL] [Abstract][Full Text] [Related]
39. Genetic determinants of survival in progressive supranuclear palsy: a genome-wide association study.
Jabbari E; Koga S; Valentino RR; Reynolds RH; Ferrari R; Tan MMX; Rowe JB; Dalgard CL; Scholz SW; Dickson DW; Warner TT; Revesz T; Höglinger GU; Ross OA; Ryten M; Hardy J; Shoai M; Morris HR;
Lancet Neurol; 2021 Feb; 20(2):107-116. PubMed ID: 33341150
[TBL] [Abstract][Full Text] [Related]
40. Differentiation of progressive supranuclear palsy: clinical, imaging and laboratory tools.
Liscic RM; Srulijes K; Gröger A; Maetzler W; Berg D
Acta Neurol Scand; 2013 May; 127(5):362-70. PubMed ID: 23406296
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
